Medivie Therapeutic Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was ILS 180,000 compared to ILS 67,000 a year ago. Operating loss was ILS 11.583 million compared to ILS 3.715 million a year ago. Net loss was ILS 10.325 million compared to ILS 3.351 million a year ago. Basic loss per share from continuing operations was ILS 3.18 compared to ILS 1.49 a year ago.